Search results for "ovary"

showing 10 items of 341 documents

Altered Regulation of Insulin-Like Growth Factor Binding Protein-I in Patients With Polycystic Ovary Syndrome

1995

Insulin-like growth factor (IGF-I) action is influenced by circulating as well as tissue levels of its binding proteins. Because serum IGF binding protein-1 (IGFBP-1) levels have been found to be decreased in patients with polycystic ovary syndrome (PCOS), we tested the hypothesis that regulation of IGFBP-1 secretion may be different in patients with PCOS compared with normal women. We studied 15 normal ovulatory women and 15 women with PCOS of similar age (21 ± 1 and 22 ± 1 years, respectively). All subjects were studied after an overnight fast between days 5–8 after spontaneous or progestin-induced menses. Perturbations included the administration of insulin intravenously, maintenance of …

medicine.medical_specialty030219 obstetrics & reproductive medicineInsulinmedicine.medical_treatmentGrowth factorSerum insulinObstetrics and GynecologyOctreotideBiologyPolycystic ovaryInsulin-like growth factor-binding protein03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinemedicinebiology.proteinIn patientSecretion030217 neurology & neurosurgerymedicine.drugJournal of the Society for Gynecologic Investigation
researchProduct

Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis.

2020

The aim of this meta-analysis was to evaluate the prevalence of acne among women with PCOS worldwide, and in subgroups of patients with different age, geographical-region, and PCOS definition-criteria, compared to healthy non-PCOS counterparts. A comprehensive literature search was performed in PubMed (including Medline), Web of Science, and Scopus databases for retrieving articles in English investigating the prevalence of PCOS. ‘Meta-prop’ method was applied to estimate pooled prevalence of acne in both groups. Meta-regression was conducted to find the association between acne in women with and without PCOS. We used 60 studies, included data of 240,213 women with PCOS and 1,902,022 health…

medicine.medical_specialty030219 obstetrics & reproductive medicineendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismObstetrics and Gynecologynutritional and metabolic diseases030209 endocrinology & metabolismmedicine.diseasePolycystic ovaryDermatologyfemale genital diseases and pregnancy complications03 medical and health sciences0302 clinical medicineEndocrinologyMeta-analysisAcne VulgarismedicinePrevalenceHumansFemalebusinessAcnePolycystic Ovary SyndromeGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

16α-Iodo-3,17β-estradiol: A stable ligand for estrogen receptor determinations in tissues with high 17β-hydroxysteroid dehydrogenase activity

1983

Recently, the successful synthesis of radioiodinated 16 alpha-iodo-3,17 beta-estradiol-[125I] [125I]E2 was reported [1]. This new ligand has similar binding characteristics to the estrogen receptor (ER) [2-5] as the currently used tritium labeled estradiol [3H]E2. However, it offers several advantageous features: (a) high specific activity (theoretically 2,000 Ci/mmol) [1]; (b) minor problems with radioactive waste due to its short half life and (c) the possibility of simultaneous determination of ER and progesterone receptors (PgR) by double labeling with [125I]E2 and [3H]R5020 [6, 7]. As we are presently trying to determine ER and PgR in human placental cytosols we were interested in the …

medicine.medical_specialty17-Hydroxysteroid DehydrogenasesPlacentaEstrogen receptorEstroneOvaryLigandsTritiumEndometriumBiochemistryIodine Radioisotopeschemistry.chemical_compoundEndocrinologyPregnancyInternal medicinemedicineHumansHydroxysteroid dehydrogenaseReceptorEstradiolChemistryHalf-lifeLigand (biochemistry)Kineticsmedicine.anatomical_structureEndocrinologyReceptors EstrogenBiochemistryFemalehormones hormone substitutes and hormone antagonistsJournal of Steroid Biochemistry
researchProduct

Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”

2021

medicine.medical_specialty2019-20 coronavirus outbreakHirsutismCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19Dermatologymedicine.diseaseDermatologyCorrespondenceAcne VulgarisAndrogensMedicineHumansFemalebusinesshirsutismAcnePolycystic Ovary SyndromeInternational Journal of Dermatology
researchProduct

Ovarian volume in normal and hyperandrogenic adolescent women

2015

Objective To study the threshold for increased ovarian size during different periods of adolescence. Design Cross sectional study with retrospective analysis. Setting University center. Patient(s) A total of 146 hyperandrogenic adolescent women and 72 healthy adolescent controls. Intervention(s) Intravaginal or transabdominal ovarian sonography. Main Outcome Measure(s) Determination of normal ovarian size during the different phases of adolescence calculated using the ellipsoid formula; calculation of threshold for increased ovarian size during different adolescent gynecologic ages and prevalence of increased ovarian size for hyperandrogenic girls at different gynecologic ages. Result(s) In…

medicine.medical_specialtyAdolescentendocrine system diseasesCross-sectional studyRetrospective analysisHumansMedicineChildRetrospective StudiesUltrasonographyGynecologybusiness.industryOvaryHyperandrogenismAge FactorsOutcome measuresObstetrics and GynecologyOrgan Sizemedicine.diseasePolycystic ovaryCross-Sectional StudiesReproductive MedicineMenarcheFemaleHyperandrogenismbusinessFertility and Sterility
researchProduct

Polycystic ovary syndrome: metabolic consequences and long-term management.

2014

Young women with polycystic ovary syndrome (PCOS) present an increased risk for type II diabetes and cardiovascular diseases. The prevalence of altered glucose tolerance ranges between 20 and 35 % in patients while the prevalence of type II diabetes ranges between 2 and 8 % and seems related to body weight and ethnic group. Moving from the young fertile age to the 40s and the menopause the prevalence of type II diabetes continues to increase compared to the general female population and may reach 10-16 % of PCOS women. However, prevalence of altered glucose tolerance does not increase. Also cardiovascular risk is increased in a large part of young PCOS women but this risk tends to be normal…

medicine.medical_specialtyAgingClinical BiochemistryPhysiologyAge DistributionRisk FactorsInternal medicineLong term managementmedicineHumansIn patientbusiness.industryGeneral Medicinemedicine.diseasePolycystic ovaryObesityAndrogen secretionMenopausePostmenopauseYoung ageEndocrinologyIncreased riskDiabetes Mellitus Type 2Cardiovascular DiseasesFemalebusinessPolycystic Ovary SyndromeScandinavian journal of clinical and laboratory investigation. Supplementum
researchProduct

The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome.

2021

Background. Polycystic ovary syndrome (PCOS) and hypothyroidism are the most common endocrinological disorders among women of reproductive age. Since hypothyroidism occurs more frequently in PCOS patients, it is vital to explain its clinical impact. Aim. To evaluate the impact of subclinical hypothyroidism (SCH) and its treatment on the metabolic profile of patients with PCOS. Methods. 190 women with PCOS phenotype A were enrolled in the case-control study. They were divided into three groups: 38 women with PCOS and subclinical hypothyroidism, 76 women with PCOS and SCH under thyroid replacement therapy, and 76 women with PCOS and normal thyroid function (control group). Serum lipids, fasti…

medicine.medical_specialtyArticle Subjectendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBlood lipidsDiseases of the endocrine glands. Clinical endocrinologychemistry.chemical_compoundEndocrinologyInsulin resistanceInternal medicineMedicineSubclinical infectionEndocrine and Autonomic Systemsbusiness.industryCholesterolInsulinThyroidnutritional and metabolic diseasesRC648-665medicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structurechemistryThyroid functionbusinessResearch ArticleInternational journal of endocrinology
researchProduct

Control of ovarian steroidogenesis in insects: A locust neurohormone is active in vitro on blowfly ovaries

2009

0016-6480 doi: DOI: 10.1016/j.ygcen.2009.04.034; Ovarian steroidogenesis controlling insect reproduction is mainly regulated by brain gonadotropins liberated from corpora cardiaca (CC). Till now, different neurohormones have been identified in two insect groups only, locusts and mosquitoes, and it is unknown whether they could be active in other insects. In order to complete previous observations on the control of ovarian steroidogenesis in the blowfly, Phormia regina, we examined whether neuropeptides isolated from locust CC have an effect in vitro on ovarian steroidogenesis in our dipteran model. Our experiments showed that crude extracts from locust CC efficiently stimulated steroidogene…

medicine.medical_specialtyEcdysoneNeuroparsinmedia_common.quotation_subjectNeuropeptideInsectGrasshopperschemistry.chemical_compoundEndocrinologyInternal medicineInsect reproductionmedicineAnimalsChromatography High Pressure Liquidmedia_commonNeurotransmitter AgentsbiologyDipteraOvaryVitellogenesisPhormia reginabiology.organism_classificationInsulin-like peptidesIn vitroEndocrinologychemistryInsect HormonesAnimal Science and ZoologyFemaleVitellogenesisEcdysoneLocustHormoneBombyxin
researchProduct

Cyclic AMP-dependent and independent stimulations of ovarian steroidogenesis by brain factors in the blowfly, Phormia regina.

2000

0303-7207 doi: DOI: 10.1016/S0303-7207(00)00312-9; The involvement of cyclic-AMP (cAMP) as a potential second messenger in the neurohormonal control of ovarian steroidogenesis was investigated in the adult female blowfly Phormia regina. Individual measurements of ovarian cAMP concentrations and of ovarian biosynthesis of ecdysteroids, stimulated after a protein meal, demonstrated that steroidogenesis is preceded by a peak of cAMP in the ovaries. In vitro, ovarian steroidogenesis was stimulated by cell-permeable analogues of cAMP and by forskolin. Crude brain extracts were also able to elicit a rise of cAMP in the ovaries in vitro and the secretion of ecdysteroids into the medium: such extra…

medicine.medical_specialtyEcdysonePhosphodiesterase InhibitorsOˆgenesisStimulationBiochemistryOogenesis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicine1-Methyl-3-isobutylxanthinemedicineCyclic AMPAnimalsEnzyme InhibitorsMolecular Biology030304 developmental biologyBrain Chemistry0303 health sciencesEcdysteroidForskolinbiologyDipteraColforsinOvaryAge FactorsEcdysteroidsPhormia reginaThionucleotidesbiology.organism_classificationEndocrinologychemistryInsect HormonesSecond messenger systemCell signaling (fly ovary)FemaleSteroidsDietary Proteins030217 neurology & neurosurgeryEcdysteroid secretionEcdysoneAdenylyl CyclasesSignal TransductionMolecular and cellular endocrinology
researchProduct

Genetic and environmental aspect of polycystic ovary syndrome.

2004

Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationBiologyEatingEndocrinologyInsulin resistanceInternal medicineInsulin receptor substratemedicineHumansGenetic Predisposition to DiseaseObesityeducationGeneeducation.field_of_studyHyperandrogenismmedicine.diseaseObesityPhenotypePolycystic ovaryEndocrinologyFemaleInsulin ResistanceEnergy MetabolismHyperandrogenismPolycystic Ovary SyndromeJournal of endocrinological investigation
researchProduct